Letters to HCPs
Important information for Healthcare Professionals
DHPC: GLOBAL RECALL of Zerbaxa (ceftolozane / tazobactam) 1 g/0.5 g powder for concentrate for solution for infusion
This letter to HCPs gives details around the global recall of the product in December 2020 and the advice to immediately discontinue its use.
For Healthcare Professionals